Revitalizing personalized medicine

Respecting biomolecular complexities beyond gene expression

D. Jayachandran, U. Ramkrishna, J. Skiles, Jamie Renbarger, D. Ramkrishna

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Despite recent advancements in "omic" technologies, personalized medicine has not realized its fullest potential due to isolated and incomplete application of gene expression tools. In many instances, pharmacogenomics is being interchangeably used for personalized medicine, when actually it is one of the many facets of personalized medicine. Herein, we highlight key issues that are hampering the advancement of personalized medicine and highlight emerging predictive tools that can serve as a decision support mechanism for physicians to personalize treatments.

Original languageEnglish
Article numbere110
JournalCPT: Pharmacometrics and Systems Pharmacology
Volume3
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Precision Medicine
Gene expression
Medicine
Gene Expression
Pharmacogenetics
Bioelectric potentials
Decision Support
Facet
Technology
Physicians
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Revitalizing personalized medicine : Respecting biomolecular complexities beyond gene expression. / Jayachandran, D.; Ramkrishna, U.; Skiles, J.; Renbarger, Jamie; Ramkrishna, D.

In: CPT: Pharmacometrics and Systems Pharmacology, Vol. 3, No. 4, e110, 2014.

Research output: Contribution to journalArticle

@article{d333955c7843479e960cb46b7c5ac20e,
title = "Revitalizing personalized medicine: Respecting biomolecular complexities beyond gene expression",
abstract = "Despite recent advancements in {"}omic{"} technologies, personalized medicine has not realized its fullest potential due to isolated and incomplete application of gene expression tools. In many instances, pharmacogenomics is being interchangeably used for personalized medicine, when actually it is one of the many facets of personalized medicine. Herein, we highlight key issues that are hampering the advancement of personalized medicine and highlight emerging predictive tools that can serve as a decision support mechanism for physicians to personalize treatments.",
author = "D. Jayachandran and U. Ramkrishna and J. Skiles and Jamie Renbarger and D. Ramkrishna",
year = "2014",
doi = "10.1038/psp.2014.6",
language = "English",
volume = "3",
journal = "CPT: Pharmacometrics and Systems Pharmacology",
issn = "2163-8306",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Revitalizing personalized medicine

T2 - Respecting biomolecular complexities beyond gene expression

AU - Jayachandran, D.

AU - Ramkrishna, U.

AU - Skiles, J.

AU - Renbarger, Jamie

AU - Ramkrishna, D.

PY - 2014

Y1 - 2014

N2 - Despite recent advancements in "omic" technologies, personalized medicine has not realized its fullest potential due to isolated and incomplete application of gene expression tools. In many instances, pharmacogenomics is being interchangeably used for personalized medicine, when actually it is one of the many facets of personalized medicine. Herein, we highlight key issues that are hampering the advancement of personalized medicine and highlight emerging predictive tools that can serve as a decision support mechanism for physicians to personalize treatments.

AB - Despite recent advancements in "omic" technologies, personalized medicine has not realized its fullest potential due to isolated and incomplete application of gene expression tools. In many instances, pharmacogenomics is being interchangeably used for personalized medicine, when actually it is one of the many facets of personalized medicine. Herein, we highlight key issues that are hampering the advancement of personalized medicine and highlight emerging predictive tools that can serve as a decision support mechanism for physicians to personalize treatments.

UR - http://www.scopus.com/inward/record.url?scp=84902509229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902509229&partnerID=8YFLogxK

U2 - 10.1038/psp.2014.6

DO - 10.1038/psp.2014.6

M3 - Article

VL - 3

JO - CPT: Pharmacometrics and Systems Pharmacology

JF - CPT: Pharmacometrics and Systems Pharmacology

SN - 2163-8306

IS - 4

M1 - e110

ER -